| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |